These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9485177

  • 1. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
    Taga M, Shirashu K, Minaguchi H.
    Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
    [Abstract] [Full Text] [Related]

  • 2. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
    Taga M, Uemura T, Minaguchi H.
    J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
    [Abstract] [Full Text] [Related]

  • 3. Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium.
    Yamaga A, Taga M, Minaguchi H.
    Endocr J; 1997 Oct; 44(5):733-8. PubMed ID: 9466331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
    Gorai I, Taguchi Y, Chaki O, Nakayama M, Minaguchi H.
    Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
    [Abstract] [Full Text] [Related]

  • 6. Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis.
    Kawana K, Takahashi M, Hoshino H, Kushida K.
    Clin Chim Acta; 2002 Feb; 316(1-2):109-15. PubMed ID: 11750280
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 9. Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.
    Reginster JY, Henrotin Y, Christiansen C, Gamwell-Henriksen E, Bruyere, Collette J, Christgau S.
    Calcif Tissue Int; 2001 Sep; 69(3):130-7. PubMed ID: 11683527
    [Abstract] [Full Text] [Related]

  • 10. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME.
    Osteoporos Int; 1999 Sep; 9(5):449-54. PubMed ID: 10550465
    [Abstract] [Full Text] [Related]

  • 11. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 12. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ.
    J Bone Miner Res; 1999 May 15; 14(5):792-801. PubMed ID: 10320528
    [Abstract] [Full Text] [Related]

  • 13. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, Sebert JL.
    J Clin Endocrinol Metab; 1996 Oct 15; 81(10):3717-21. PubMed ID: 8855828
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD.
    J Clin Endocrinol Metab; 1996 Sep 15; 81(9):3366-71. PubMed ID: 8784098
    [Abstract] [Full Text] [Related]

  • 17. The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures.
    Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T.
    Osteoporos Int; 1999 Sep 15; 9(5):405-9. PubMed ID: 10550459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC.
    Adv Med Sci; 2009 Sep 15; 54(1):1-6. PubMed ID: 19482729
    [Abstract] [Full Text] [Related]

  • 20. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S, Pacitti MT, Rosso R, Pellegrino C, Ombricolo E, Pisani D, Romagnoli E, Damiani C, Aliberti G, Scarda A, Mazzuoli SF.
    J Endocrinol Invest; 1997 Oct 15; 20(9):559-65. PubMed ID: 9413811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.